Shasun Pharmaceuticals lost 3.24% to Rs 149.50 at 10:53 IST on BSE after the company reported consolidated net loss of Rs 4.80 crore in Q1 June 2014, lower than net loss of Rs 6.57 crore in Q1 June 2013.
The Q1 result was announced after market hours on Wednesday, 6 August 2014.
Meanwhile, the S&P BSE Sensex was down 57.56 points or 0.22% at 25,607.71.
On BSE, so far 1.24 lakh shares were traded in the counter as against average daily volume of 2.01 lakh shares in the past two weeks.
The stock hit a high of Rs 154 and a low of Rs 146 so far during the day.
Shasun Pharmaceuticals (Shasun) attributed the loss in Q1 June 2014 mainly to phasing of orders in UK operations.
Shasun's consolidated gross revenue rose 38% to Rs 313.72 crore in Q1 June 2014 over Q1 June 2013. EBITDA after R&D cost rose 190.45% to Rs 21 crore in Q1 June 2014 over Q1 June 2013.
Shasun Pharmaceuticals is an integrated pharmaceutical company with locations in India, UK and USA.
Powered by Capital Market - Live News
